Epivara provides a single-injection alternative to spay and neuter surgery.
Epivara has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
Epivara's investors include National Science Foundation.
Epivara is headquartered in Champaign, United States.
Epivara provides a single-injection alternative to spay and neuter surgery.
Epivara is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epivara — Funding & Investors." VCBacked, February 18, 2025, https://www.vcbacked.co/company/epivara. Accessed August 16, 2026.
VCBacked. (2025). Epivara — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/epivara
{{cite web |title=Epivara — Funding & Investors |url=https://www.vcbacked.co/company/epivara |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated